November 2025
The global cardiovascular drugs market size is valued at USD 155.96 billion in 2025 and is expected to hit around USD 214.72 billion by 2034, growing at a CAGR of 3.62% from 2025 to 2034.
June 2026
The US cardiovascular drugs market size was evaluated at USD 28.42 billion in 2025 and is predicted to hit around USD 37.03 billion by 2035, growing at a CAGR of 2.68%.
July 2025
The global fibrate drugs market size was valued at USD 3.42 billion in 2024 and is projected to attain around USD 5.67 billion by 2034 with a CAGR of 5.19%.
July 2025
The global lipid-lowering drugs market size was evaluated at USD 34.27 billion in 2024 and is projected to attain around USD 48.11 billion by 2034 with a CAGR of 3.45%.
June 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
June 2026
The global head and neck cancer drugs market size surpassed USD 18.78 billion in 2025 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
June 2026
The global over the counter (OTC) drugs market size is expected to increase from USD 135.25 billion in 2025 and is expected to hit USD 256.87 billion by 2035, growing at a CAGR of 6.62%
June 2026
The global DNA repair drugs market size reached USD 9.36 billion in 2025 and is predicted to surpass around USD 33.11 billion by 2035 with a notable CAGR of 13.47%.
June 2026
The U.S. over the counter (OTC) drugs market size is expected to increase from USD 24.81 billion in 2025 and is predicted to hit USD 46.67 billion by 2035, with a CAGR of 6.52%.
June 2026
The global critical care drugs market size was evaluated at USD 1.22 billion in 2025 and is projected to surge around USD 2.00 billion by 2035, with a CAGR of 5.07%.
June 2026
The global pingueculum drugs market size was evaluated at USD 832.14 million in 2025 and is predicted to hit around USD 1,660.04 million by 2035, growing at a CAGR of 7.15%.
May 2026
The global hyperlipidemia drugs market size is calculated at USD 23.85 billion in 2025 and is projected to surpass USD 35.24 billion by 2035 with a CAGR of 3.98%.
May 2026
The global pain management drugs market size was valued at USD 87.19 billion in 2025 and is expected to hit around USD 130.8 billion by 2035, growing at a CAGR of 4.14%.
May 2026
The U.S. pain management drugs market size was estimated at USD 32.79 billion in 2025 and is projected to hit around USD 46.50 billion by 2035, at a CAGR of 3.56%.
May 2026
The global HIV drugs market size is estimated at USD 38.47 billion in 2025 and is projected to hit around USD 69.88 billion by 2035, growing at a CAGR of 6.15%.
May 2026
The global antifungal drugs market size was exhibited at USD 18.00 billion in 2025 and is projected to hit around USD 25.34 billion by 2035 with a CAGR of 3.49%.
May 2026
The global antiepileptic drugs market size was evaluated at USD 18.03 billion in 2025 and is predicted to hit around USD 30.80 billion by 2035, growing at a CAGR of 5.50%.
May 2026
The global sedative-hypnotic drugs market size was evaluated at USD 15.64 billion in 2025 and is predicted to hit around USD 31.94 billion by 2035, growing at a CAGR of 7.40%.
May 2026
The global synthetic lethality-based drugs and targets market size was evaluated at USD 1.86 billion in 2025 and is predicted to hit around USD 9.37 billion by 2035, growing at a CAGR of 17.52%.
May 2026
The global injectable peptides drugs market size was evaluated at USD 48.60 billion in 2025 and is predicted to hit around USD 117.18 billion by 2035, growing at a CAGR of 9.20%.
April 2026
The global antipsychotic drugs market size was valued at USD 19.61 billion in 2025 and is projected to cross around USD 34.86 billion by 2035 with a CAGR of 5.92%.
April 2026
The contraceptive drugs and devices market size reached USD 33.26 billion in 2025 and is projected to surpass around USD 58.87 billion by 2035, with a notable CAGR of 5.88%.
April 2026
The genitourinary drugs market size size is expected to increase to USD 33.51 billion by 2035 from USD 30.04 billion in 2025 with a CAGR 1.10%.
April 2026
The global multiple sclerosis drugs market size is estimated to hit around USD 49.13 billion by 2035, increasing from USD 22.96 billion in 2025, with a CAGR of 7.90%.
April 2026
The global amylin analog drugs market size was evaluated at USD 3.20 billion in 2025 and is predicted to hit around USD 7.10 billion by 2035, growing at a CAGR of 8.30%.
April 2026
The global ovarian cancer drugs market size was evaluated at USD 4.09 billion in 2025 and is predicted to hit around USD 7.78 billion by 2035, growing at a CAGR of 6.64%.
March 2026
The global veterinary dermatology drugs market size is expected to increase from USD 8.96 billion in 2025 and is projected to hit around USD 20.62 billion by 2035 with a CAGR of 8.69%.
March 2026
The global contraceptive drugs market size is valued at USD 19.00 billion in 2025 and is expected to hit around USD 33.23 billion by 2035, at a CAGR of 5.75%.
March 2026
The global intravenous iron drugs market size was valued at USD 3.84 billion in 2025 and is expected to attain around USD 8.82 billion by 2035 at a CAGR of 8.67%.
March 2026
The global kidney cancer drugs market size is calculated at USD 7.24 billion in 2025 and is projected to hit around USD 12.16 billion by 2035 with a CAGR of 5.32%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com